Clinical Trial: Radiofrequency Ablation Plus Botulinum Toxin Injection Versus Radiofrequency Ablation Only in Patients With Atrial Flutter
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Radiofrequency Ablation Plus Botulinum Toxin Injection Versus Radiofrequency Ablation Only in Patients With Atrial Flutter to Prevent Post-procedural Atrial Fibrillation
Brief Summary: The aim of this randomized study was to assess the effectiveness of endomyocardial botulinum toxin injection for preventing post-procedural atrial fibrillation in patients undergoing the radiofrequency ablation of atrial flutter.
Detailed Summary:
Sponsor: Meshalkin Research Institute of Pathology of Circulation
Current Primary Outcome: number of paroxysms of atrial fibrillation [ Time Frame: 1 year ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- AF burden [ Time Frame: 1 year ]
- serious adverse events [ Time Frame: 1 year ]
Original Secondary Outcome: Same as current
Information By: Meshalkin Research Institute of Pathology of Circulation
Dates:
Date Received: December 2, 2013
Date Started: June 2013
Date Completion: January 2016
Last Updated: September 21, 2015
Last Verified: September 2015
